nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—Urinary retention—Vincristine—muscle cancer	0.00863	0.00863	CcSEcCtD
Atomoxetine—Dysuria—Vincristine—muscle cancer	0.00733	0.00733	CcSEcCtD
Atomoxetine—Erectile dysfunction—Vincristine—muscle cancer	0.00722	0.00722	CcSEcCtD
Atomoxetine—Weight decreased—Vincristine—muscle cancer	0.00709	0.00709	CcSEcCtD
Atomoxetine—Depression—Vincristine—muscle cancer	0.00697	0.00697	CcSEcCtD
Atomoxetine—Bone disorder—Methotrexate—muscle cancer	0.00671	0.00671	CcSEcCtD
Atomoxetine—Flushing—Dactinomycin—muscle cancer	0.00652	0.00652	CcSEcCtD
Atomoxetine—Rigors—Doxorubicin—muscle cancer	0.00643	0.00643	CcSEcCtD
Atomoxetine—Chills—Dactinomycin—muscle cancer	0.0063	0.0063	CcSEcCtD
Atomoxetine—Hallucination—Vincristine—muscle cancer	0.00624	0.00624	CcSEcCtD
Atomoxetine—Hypoaesthesia—Vincristine—muscle cancer	0.00624	0.00624	CcSEcCtD
Atomoxetine—Urinary tract disorder—Vincristine—muscle cancer	0.0062	0.0062	CcSEcCtD
Atomoxetine—Sweating increased—Etoposide—muscle cancer	0.00619	0.00619	CcSEcCtD
Atomoxetine—Urethral disorder—Vincristine—muscle cancer	0.00615	0.00615	CcSEcCtD
Atomoxetine—Delirium—Doxorubicin—muscle cancer	0.00611	0.00611	CcSEcCtD
Atomoxetine—Cardiac disorder—Vincristine—muscle cancer	0.00582	0.00582	CcSEcCtD
Atomoxetine—Bone disorder—Doxorubicin—muscle cancer	0.00581	0.00581	CcSEcCtD
Atomoxetine—Angiopathy—Vincristine—muscle cancer	0.00569	0.00569	CcSEcCtD
Atomoxetine—Infestation NOS—Etoposide—muscle cancer	0.00566	0.00566	CcSEcCtD
Atomoxetine—Infestation—Etoposide—muscle cancer	0.00566	0.00566	CcSEcCtD
Atomoxetine—Mediastinal disorder—Vincristine—muscle cancer	0.00566	0.00566	CcSEcCtD
Atomoxetine—Coma—Methotrexate—muscle cancer	0.00554	0.00554	CcSEcCtD
Atomoxetine—Mental disorder—Vincristine—muscle cancer	0.0055	0.0055	CcSEcCtD
Atomoxetine—Back pain—Vincristine—muscle cancer	0.00528	0.00528	CcSEcCtD
Atomoxetine—Myalgia—Dactinomycin—muscle cancer	0.00521	0.00521	CcSEcCtD
Atomoxetine—Abnormal dreams—Doxorubicin—muscle cancer	0.00519	0.00519	CcSEcCtD
Atomoxetine—Hypoaesthesia—Etoposide—muscle cancer	0.00506	0.00506	CcSEcCtD
Atomoxetine—Urinary tract disorder—Etoposide—muscle cancer	0.00502	0.00502	CcSEcCtD
Atomoxetine—Agitation—Vincristine—muscle cancer	0.00502	0.00502	CcSEcCtD
Atomoxetine—Urethral disorder—Etoposide—muscle cancer	0.00498	0.00498	CcSEcCtD
Atomoxetine—Infection—Dactinomycin—muscle cancer	0.00496	0.00496	CcSEcCtD
Atomoxetine—Vertigo—Vincristine—muscle cancer	0.00491	0.00491	CcSEcCtD
Atomoxetine—Hepatic failure—Methotrexate—muscle cancer	0.0049	0.0049	CcSEcCtD
Atomoxetine—Coma—Doxorubicin—muscle cancer	0.0048	0.0048	CcSEcCtD
Atomoxetine—Anorexia—Dactinomycin—muscle cancer	0.00476	0.00476	CcSEcCtD
Atomoxetine—Convulsion—Vincristine—muscle cancer	0.00473	0.00473	CcSEcCtD
Atomoxetine—Flushing—Etoposide—muscle cancer	0.00472	0.00472	CcSEcCtD
Atomoxetine—Cardiac disorder—Etoposide—muscle cancer	0.00472	0.00472	CcSEcCtD
Atomoxetine—Myalgia—Vincristine—muscle cancer	0.00465	0.00465	CcSEcCtD
Atomoxetine—Angiopathy—Etoposide—muscle cancer	0.00461	0.00461	CcSEcCtD
Atomoxetine—Mediastinal disorder—Etoposide—muscle cancer	0.00458	0.00458	CcSEcCtD
Atomoxetine—Chills—Etoposide—muscle cancer	0.00456	0.00456	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00455	0.00455	CcSEcCtD
Atomoxetine—Lethargy—Methotrexate—muscle cancer	0.00449	0.00449	CcSEcCtD
Atomoxetine—Infection—Vincristine—muscle cancer	0.00443	0.00443	CcSEcCtD
Atomoxetine—Nervous system disorder—Vincristine—muscle cancer	0.00437	0.00437	CcSEcCtD
Atomoxetine—Decreased appetite—Dactinomycin—muscle cancer	0.00434	0.00434	CcSEcCtD
Atomoxetine—Dysgeusia—Etoposide—muscle cancer	0.00433	0.00433	CcSEcCtD
Atomoxetine—Hyperhidrosis—Vincristine—muscle cancer	0.00431	0.00431	CcSEcCtD
Atomoxetine—Fatigue—Dactinomycin—muscle cancer	0.0043	0.0043	CcSEcCtD
Atomoxetine—Back pain—Etoposide—muscle cancer	0.00428	0.00428	CcSEcCtD
Atomoxetine—Pain—Dactinomycin—muscle cancer	0.00427	0.00427	CcSEcCtD
Atomoxetine—Muscle spasms—Etoposide—muscle cancer	0.00426	0.00426	CcSEcCtD
Atomoxetine—Anorexia—Vincristine—muscle cancer	0.00425	0.00425	CcSEcCtD
Atomoxetine—Hepatic failure—Doxorubicin—muscle cancer	0.00424	0.00424	CcSEcCtD
Atomoxetine—Irritability—Methotrexate—muscle cancer	0.0042	0.0042	CcSEcCtD
Atomoxetine—Mood swings—Methotrexate—muscle cancer	0.00417	0.00417	CcSEcCtD
Atomoxetine—Feeling abnormal—Dactinomycin—muscle cancer	0.00411	0.00411	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00408	0.00408	CcSEcCtD
Atomoxetine—Hot flush—Doxorubicin—muscle cancer	0.00407	0.00407	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00406	0.00406	CcSEcCtD
Atomoxetine—Menopausal symptoms—Doxorubicin—muscle cancer	0.00404	0.00404	CcSEcCtD
Atomoxetine—Insomnia—Vincristine—muscle cancer	0.00403	0.00403	CcSEcCtD
Atomoxetine—Paraesthesia—Vincristine—muscle cancer	0.004	0.004	CcSEcCtD
Atomoxetine—Breast disorder—Methotrexate—muscle cancer	0.00398	0.00398	CcSEcCtD
Atomoxetine—Vertigo—Etoposide—muscle cancer	0.00398	0.00398	CcSEcCtD
Atomoxetine—Body temperature increased—Dactinomycin—muscle cancer	0.00395	0.00395	CcSEcCtD
Atomoxetine—Abdominal pain—Dactinomycin—muscle cancer	0.00395	0.00395	CcSEcCtD
Atomoxetine—Loss of consciousness—Etoposide—muscle cancer	0.00389	0.00389	CcSEcCtD
Atomoxetine—Lethargy—Doxorubicin—muscle cancer	0.00389	0.00389	CcSEcCtD
Atomoxetine—Decreased appetite—Vincristine—muscle cancer	0.00388	0.00388	CcSEcCtD
Atomoxetine—Cough—Etoposide—muscle cancer	0.00386	0.00386	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00385	0.00385	CcSEcCtD
Atomoxetine—Fatigue—Vincristine—muscle cancer	0.00384	0.00384	CcSEcCtD
Atomoxetine—Convulsion—Etoposide—muscle cancer	0.00383	0.00383	CcSEcCtD
Atomoxetine—Constipation—Vincristine—muscle cancer	0.00381	0.00381	CcSEcCtD
Atomoxetine—Pain—Vincristine—muscle cancer	0.00381	0.00381	CcSEcCtD
Atomoxetine—Chest pain—Etoposide—muscle cancer	0.00377	0.00377	CcSEcCtD
Atomoxetine—Affect lability—Doxorubicin—muscle cancer	0.00375	0.00375	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00374	0.00374	CcSEcCtD
Atomoxetine—Abdominal discomfort—Methotrexate—muscle cancer	0.00365	0.00365	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Vincristine—muscle cancer	0.00365	0.00365	CcSEcCtD
Atomoxetine—Mood swings—Doxorubicin—muscle cancer	0.00361	0.00361	CcSEcCtD
Atomoxetine—Infection—Etoposide—muscle cancer	0.00359	0.00359	CcSEcCtD
Atomoxetine—Asthenia—Dactinomycin—muscle cancer	0.00358	0.00358	CcSEcCtD
Atomoxetine—Dysuria—Methotrexate—muscle cancer	0.00356	0.00356	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00354	0.00354	CcSEcCtD
Atomoxetine—Tachycardia—Etoposide—muscle cancer	0.00353	0.00353	CcSEcCtD
Atomoxetine—Body temperature increased—Vincristine—muscle cancer	0.00353	0.00353	CcSEcCtD
Atomoxetine—Abdominal pain—Vincristine—muscle cancer	0.00353	0.00353	CcSEcCtD
Atomoxetine—Skin disorder—Etoposide—muscle cancer	0.00351	0.00351	CcSEcCtD
Atomoxetine—Erectile dysfunction—Methotrexate—muscle cancer	0.0035	0.0035	CcSEcCtD
Atomoxetine—Hyperhidrosis—Etoposide—muscle cancer	0.00349	0.00349	CcSEcCtD
Atomoxetine—Abdominal pain upper—Doxorubicin—muscle cancer	0.00348	0.00348	CcSEcCtD
Atomoxetine—Breast disorder—Doxorubicin—muscle cancer	0.00344	0.00344	CcSEcCtD
Atomoxetine—Anorexia—Etoposide—muscle cancer	0.00344	0.00344	CcSEcCtD
Atomoxetine—Diarrhoea—Dactinomycin—muscle cancer	0.00341	0.00341	CcSEcCtD
Atomoxetine—Nasopharyngitis—Doxorubicin—muscle cancer	0.00341	0.00341	CcSEcCtD
Atomoxetine—Infestation NOS—Methotrexate—muscle cancer	0.00339	0.00339	CcSEcCtD
Atomoxetine—Infestation—Methotrexate—muscle cancer	0.00339	0.00339	CcSEcCtD
Atomoxetine—Depression—Methotrexate—muscle cancer	0.00338	0.00338	CcSEcCtD
Atomoxetine—Conjunctivitis—Methotrexate—muscle cancer	0.0033	0.0033	CcSEcCtD
Atomoxetine—Influenza—Doxorubicin—muscle cancer	0.00329	0.00329	CcSEcCtD
Atomoxetine—Paraesthesia—Etoposide—muscle cancer	0.00324	0.00324	CcSEcCtD
Atomoxetine—Somnolence—Etoposide—muscle cancer	0.00321	0.00321	CcSEcCtD
Atomoxetine—Asthenia—Vincristine—muscle cancer	0.0032	0.0032	CcSEcCtD
Atomoxetine—Vomiting—Dactinomycin—muscle cancer	0.00317	0.00317	CcSEcCtD
Atomoxetine—Rash—Dactinomycin—muscle cancer	0.00315	0.00315	CcSEcCtD
Atomoxetine—Decreased appetite—Etoposide—muscle cancer	0.00314	0.00314	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Etoposide—muscle cancer	0.00312	0.00312	CcSEcCtD
Atomoxetine—Fatigue—Etoposide—muscle cancer	0.00311	0.00311	CcSEcCtD
Atomoxetine—Constipation—Etoposide—muscle cancer	0.00309	0.00309	CcSEcCtD
Atomoxetine—Pain—Etoposide—muscle cancer	0.00309	0.00309	CcSEcCtD
Atomoxetine—Dysuria—Doxorubicin—muscle cancer	0.00308	0.00308	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00306	0.00306	CcSEcCtD
Atomoxetine—Diarrhoea—Vincristine—muscle cancer	0.00305	0.00305	CcSEcCtD
Atomoxetine—Pollakiuria—Doxorubicin—muscle cancer	0.00304	0.00304	CcSEcCtD
Atomoxetine—Urinary tract disorder—Methotrexate—muscle cancer	0.00301	0.00301	CcSEcCtD
Atomoxetine—Urethral disorder—Methotrexate—muscle cancer	0.00299	0.00299	CcSEcCtD
Atomoxetine—Weight decreased—Doxorubicin—muscle cancer	0.00298	0.00298	CcSEcCtD
Atomoxetine—Feeling abnormal—Etoposide—muscle cancer	0.00298	0.00298	CcSEcCtD
Atomoxetine—Nausea—Dactinomycin—muscle cancer	0.00296	0.00296	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Etoposide—muscle cancer	0.00295	0.00295	CcSEcCtD
Atomoxetine—Dizziness—Vincristine—muscle cancer	0.00295	0.00295	CcSEcCtD
Atomoxetine—Infestation NOS—Doxorubicin—muscle cancer	0.00294	0.00294	CcSEcCtD
Atomoxetine—Infestation—Doxorubicin—muscle cancer	0.00294	0.00294	CcSEcCtD
Atomoxetine—Urticaria—Etoposide—muscle cancer	0.00287	0.00287	CcSEcCtD
Atomoxetine—Abdominal pain—Etoposide—muscle cancer	0.00286	0.00286	CcSEcCtD
Atomoxetine—Body temperature increased—Etoposide—muscle cancer	0.00286	0.00286	CcSEcCtD
Atomoxetine—Conjunctivitis—Doxorubicin—muscle cancer	0.00286	0.00286	CcSEcCtD
Atomoxetine—Vomiting—Vincristine—muscle cancer	0.00284	0.00284	CcSEcCtD
Atomoxetine—Cardiac disorder—Methotrexate—muscle cancer	0.00283	0.00283	CcSEcCtD
Atomoxetine—Rash—Vincristine—muscle cancer	0.00281	0.00281	CcSEcCtD
Atomoxetine—Dermatitis—Vincristine—muscle cancer	0.00281	0.00281	CcSEcCtD
Atomoxetine—Headache—Vincristine—muscle cancer	0.00279	0.00279	CcSEcCtD
Atomoxetine—Angiopathy—Methotrexate—muscle cancer	0.00276	0.00276	CcSEcCtD
Atomoxetine—Sinusitis—Doxorubicin—muscle cancer	0.00276	0.00276	CcSEcCtD
Atomoxetine—Mediastinal disorder—Methotrexate—muscle cancer	0.00274	0.00274	CcSEcCtD
Atomoxetine—Chills—Methotrexate—muscle cancer	0.00273	0.00273	CcSEcCtD
Atomoxetine—Mental disorder—Methotrexate—muscle cancer	0.00267	0.00267	CcSEcCtD
Atomoxetine—Malnutrition—Methotrexate—muscle cancer	0.00265	0.00265	CcSEcCtD
Atomoxetine—Nausea—Vincristine—muscle cancer	0.00265	0.00265	CcSEcCtD
Atomoxetine—Hypoaesthesia—Doxorubicin—muscle cancer	0.00262	0.00262	CcSEcCtD
Atomoxetine—Urinary tract disorder—Doxorubicin—muscle cancer	0.0026	0.0026	CcSEcCtD
Atomoxetine—Dysgeusia—Methotrexate—muscle cancer	0.0026	0.0026	CcSEcCtD
Atomoxetine—Asthenia—Etoposide—muscle cancer	0.00259	0.00259	CcSEcCtD
Atomoxetine—Urethral disorder—Doxorubicin—muscle cancer	0.00258	0.00258	CcSEcCtD
Atomoxetine—Back pain—Methotrexate—muscle cancer	0.00256	0.00256	CcSEcCtD
Atomoxetine—Pruritus—Etoposide—muscle cancer	0.00256	0.00256	CcSEcCtD
Atomoxetine—Vision blurred—Methotrexate—muscle cancer	0.0025	0.0025	CcSEcCtD
Atomoxetine—Diarrhoea—Etoposide—muscle cancer	0.00247	0.00247	CcSEcCtD
Atomoxetine—Flushing—Doxorubicin—muscle cancer	0.00245	0.00245	CcSEcCtD
Atomoxetine—Cardiac disorder—Doxorubicin—muscle cancer	0.00245	0.00245	CcSEcCtD
Atomoxetine—Angiopathy—Doxorubicin—muscle cancer	0.00239	0.00239	CcSEcCtD
Atomoxetine—Dizziness—Etoposide—muscle cancer	0.00239	0.00239	CcSEcCtD
Atomoxetine—Vertigo—Methotrexate—muscle cancer	0.00238	0.00238	CcSEcCtD
Atomoxetine—Mediastinal disorder—Doxorubicin—muscle cancer	0.00238	0.00238	CcSEcCtD
Atomoxetine—Chills—Doxorubicin—muscle cancer	0.00237	0.00237	CcSEcCtD
Atomoxetine—Cough—Methotrexate—muscle cancer	0.00231	0.00231	CcSEcCtD
Atomoxetine—Mental disorder—Doxorubicin—muscle cancer	0.00231	0.00231	CcSEcCtD
Atomoxetine—Convulsion—Methotrexate—muscle cancer	0.0023	0.0023	CcSEcCtD
Atomoxetine—Vomiting—Etoposide—muscle cancer	0.0023	0.0023	CcSEcCtD
Atomoxetine—Malnutrition—Doxorubicin—muscle cancer	0.0023	0.0023	CcSEcCtD
Atomoxetine—Rash—Etoposide—muscle cancer	0.00228	0.00228	CcSEcCtD
Atomoxetine—Dermatitis—Etoposide—muscle cancer	0.00228	0.00228	CcSEcCtD
Atomoxetine—Headache—Etoposide—muscle cancer	0.00226	0.00226	CcSEcCtD
Atomoxetine—Flatulence—Doxorubicin—muscle cancer	0.00226	0.00226	CcSEcCtD
Atomoxetine—Chest pain—Methotrexate—muscle cancer	0.00226	0.00226	CcSEcCtD
Atomoxetine—Myalgia—Methotrexate—muscle cancer	0.00226	0.00226	CcSEcCtD
Atomoxetine—Arthralgia—Methotrexate—muscle cancer	0.00226	0.00226	CcSEcCtD
Atomoxetine—Tension—Doxorubicin—muscle cancer	0.00225	0.00225	CcSEcCtD
Atomoxetine—Dysgeusia—Doxorubicin—muscle cancer	0.00225	0.00225	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00224	0.00224	CcSEcCtD
Atomoxetine—Nervousness—Doxorubicin—muscle cancer	0.00223	0.00223	CcSEcCtD
Atomoxetine—Back pain—Doxorubicin—muscle cancer	0.00222	0.00222	CcSEcCtD
Atomoxetine—Muscle spasms—Doxorubicin—muscle cancer	0.00221	0.00221	CcSEcCtD
Atomoxetine—Vision blurred—Doxorubicin—muscle cancer	0.00216	0.00216	CcSEcCtD
Atomoxetine—Infection—Methotrexate—muscle cancer	0.00215	0.00215	CcSEcCtD
Atomoxetine—Nausea—Etoposide—muscle cancer	0.00215	0.00215	CcSEcCtD
Atomoxetine—Nervous system disorder—Methotrexate—muscle cancer	0.00212	0.00212	CcSEcCtD
Atomoxetine—Agitation—Doxorubicin—muscle cancer	0.00211	0.00211	CcSEcCtD
Atomoxetine—Skin disorder—Methotrexate—muscle cancer	0.0021	0.0021	CcSEcCtD
Atomoxetine—Hyperhidrosis—Methotrexate—muscle cancer	0.00209	0.00209	CcSEcCtD
Atomoxetine—Vertigo—Doxorubicin—muscle cancer	0.00206	0.00206	CcSEcCtD
Atomoxetine—Anorexia—Methotrexate—muscle cancer	0.00206	0.00206	CcSEcCtD
Atomoxetine—Syncope—Doxorubicin—muscle cancer	0.00206	0.00206	CcSEcCtD
Atomoxetine—Palpitations—Doxorubicin—muscle cancer	0.00203	0.00203	CcSEcCtD
Atomoxetine—Loss of consciousness—Doxorubicin—muscle cancer	0.00202	0.00202	CcSEcCtD
Atomoxetine—Cough—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Atomoxetine—Convulsion—Doxorubicin—muscle cancer	0.00199	0.00199	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00197	0.00197	CcSEcCtD
Atomoxetine—Insomnia—Methotrexate—muscle cancer	0.00196	0.00196	CcSEcCtD
Atomoxetine—Arthralgia—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Atomoxetine—Chest pain—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Atomoxetine—Myalgia—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Atomoxetine—Anxiety—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Atomoxetine—Paraesthesia—Methotrexate—muscle cancer	0.00194	0.00194	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00194	0.00194	CcSEcCtD
Atomoxetine—Somnolence—Methotrexate—muscle cancer	0.00192	0.00192	CcSEcCtD
Atomoxetine—Dry mouth—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Atomoxetine—Dyspepsia—Methotrexate—muscle cancer	0.0019	0.0019	CcSEcCtD
Atomoxetine—Decreased appetite—Methotrexate—muscle cancer	0.00188	0.00188	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00187	0.00187	CcSEcCtD
Atomoxetine—Fatigue—Methotrexate—muscle cancer	0.00187	0.00187	CcSEcCtD
Atomoxetine—Infection—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Atomoxetine—Pain—Methotrexate—muscle cancer	0.00185	0.00185	CcSEcCtD
Atomoxetine—Shock—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Atomoxetine—Nervous system disorder—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Atomoxetine—Tachycardia—Doxorubicin—muscle cancer	0.00183	0.00183	CcSEcCtD
Atomoxetine—Skin disorder—Doxorubicin—muscle cancer	0.00182	0.00182	CcSEcCtD
Atomoxetine—Hyperhidrosis—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Atomoxetine—Anorexia—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Atomoxetine—Feeling abnormal—Methotrexate—muscle cancer	0.00178	0.00178	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Methotrexate—muscle cancer	0.00177	0.00177	CcSEcCtD
Atomoxetine—Urticaria—Methotrexate—muscle cancer	0.00172	0.00172	CcSEcCtD
Atomoxetine—Body temperature increased—Methotrexate—muscle cancer	0.00171	0.00171	CcSEcCtD
Atomoxetine—Abdominal pain—Methotrexate—muscle cancer	0.00171	0.00171	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00171	0.00171	CcSEcCtD
Atomoxetine—Insomnia—Doxorubicin—muscle cancer	0.00169	0.00169	CcSEcCtD
Atomoxetine—Paraesthesia—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Atomoxetine—Somnolence—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Atomoxetine—Dyspepsia—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Atomoxetine—Decreased appetite—Doxorubicin—muscle cancer	0.00163	0.00163	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Atomoxetine—Fatigue—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Atomoxetine—Pain—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Atomoxetine—Constipation—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Atomoxetine—Asthenia—Methotrexate—muscle cancer	0.00155	0.00155	CcSEcCtD
Atomoxetine—Feeling abnormal—Doxorubicin—muscle cancer	0.00154	0.00154	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Atomoxetine—Pruritus—Methotrexate—muscle cancer	0.00153	0.00153	CcSEcCtD
Atomoxetine—Urticaria—Doxorubicin—muscle cancer	0.00149	0.00149	CcSEcCtD
Atomoxetine—Body temperature increased—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Atomoxetine—Abdominal pain—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Atomoxetine—Diarrhoea—Methotrexate—muscle cancer	0.00148	0.00148	CcSEcCtD
Atomoxetine—Dizziness—Methotrexate—muscle cancer	0.00143	0.00143	CcSEcCtD
Atomoxetine—Vomiting—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Atomoxetine—Rash—Methotrexate—muscle cancer	0.00136	0.00136	CcSEcCtD
Atomoxetine—Dermatitis—Methotrexate—muscle cancer	0.00136	0.00136	CcSEcCtD
Atomoxetine—Headache—Methotrexate—muscle cancer	0.00136	0.00136	CcSEcCtD
Atomoxetine—Asthenia—Doxorubicin—muscle cancer	0.00134	0.00134	CcSEcCtD
Atomoxetine—Pruritus—Doxorubicin—muscle cancer	0.00133	0.00133	CcSEcCtD
Atomoxetine—Nausea—Methotrexate—muscle cancer	0.00129	0.00129	CcSEcCtD
Atomoxetine—Diarrhoea—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Atomoxetine—Dizziness—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Atomoxetine—Vomiting—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Atomoxetine—Rash—Doxorubicin—muscle cancer	0.00118	0.00118	CcSEcCtD
Atomoxetine—Dermatitis—Doxorubicin—muscle cancer	0.00118	0.00118	CcSEcCtD
Atomoxetine—Headache—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Atomoxetine—Nausea—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
